October 20, 2020

Toxic Cellular Ooze Linked to Biological Age, Disease and Disability

By Susan Murphy
Illustration of normal cells (pink) and senescent cells (green).
Credit: Donna DeSmet, Mayo Clinic medical illustration/animation

By Sara Tiner

Cells in the body usually do what they’re told. In response to cues, cells divide, grow, shrink or die as needed. But there are some cells that start to ignore the body’s order to expire: senescent cells. Sometimes called "zombie cells" for their undead lingering, senescent cells have triggered the body’s kill command, but instead of dying, they exist in a sort of suspended reality, unable to work properly but actively spewing out toxic chemicals.

Animal studies have implicated senescent cells in conditions of aging ranging from brain dysfunction to osteoporosis, but research on senescent cells and their contribution to poor health is still fairly new. The primary focus has been on senescent cells themselves and how removing them affects disease states. Now researchers are looking at the toxic proteins released by senescent cells, called the senescence-associated secretory phenotype, or SASP. They are examining the effect of those proteins in the environment around the cells (microenvironment) and as they circulate through the body.

In a recent study, Mayo Clinic researchers report that the SASP circulating in the human bloodstream might be a reliable marker for distinguishing who is at risk for age-related diseases as well as poor outcomes after surgery. The article published online June 18, 2020, in the journal JCI Insight. Led by the lab of Mayo researcher Nathan LeBrasseur, Ph.D., a collaboration of colleagues assembled to understand how the toxic factors from senescent cells may mirror biological age and, correspondingly, heightened risk for medical procedures.

The study’s co-first authors from left: Marissa Schafer, Ph.D., Dr. LeBrasseur and Xu Zhang, Ph.D.

“We first developed a panel of approximately 30 senescence biomarkers by examining the abundance of diverse proteins secreted by various types of human senescent cells,” says Dr. LeBrasseur. “We then assessed whether they were detectable in human blood samples.”

The researchers looked for those proteins in blood samples of Mayo Clinic Biobank participants. The 267 samples were evenly distributed in donor sex and age from 20–90.

“We show the circulating abundance of the majority of our biomarkers increased with advancing age,” says Dr. LeBrasseur.

Concentrations of 19 biomarkers were associated with chronological age, and, after adjustments for sex and body weight index, 17 remained. This, the authors write, showcases the importance of these factors on the body and how it ages. They conclude that as different types of senescent cells accumulate with age, they may contribute to a personalized and changing SASP within each person.

In addition to looking at the biomarkers in relatively healthy biobank participants, the researchers also measured the circulating SASP proteins in persons with two distinct age-related conditions requiring surgery: cardiovascular disease (severe aortic stenosis) and ovarian cancer. Dr. LeBrasseur and colleagues examined the associations between biomarkers and an index of frailty, which is a geriatric syndrome linked to increased vulnerability to stress and poor health outcomes after surgery in both groups.

"We observed that several of our biomarkers were associated with the burden of diseases and disabilities, or biological age,” says Dr. LeBrasseur. “Using machine learning, we identified a select group of biomarkers that could be used to predict adverse outcomes, such as complications, intensive care unit admissions and rehospitalizations after surgery for either heart disease or ovarian cancer.”

Notably, biomarkers were significantly better at predicting adverse health outcomes than chronological age and the frailty measure.        

Amanda Heeren and Dr. LeBrasseur in the lab, preparing human blood samples to measure senescence biomarkers. As interventions that target the fundamental biology of aging emerge, biomarkers of aging can help us identify individuals who will be most responsive.

The authors caution that the study draws from a limited geographic area and may not be generalizable. They also note that the utility of the biomarkers needs to be tested in other surgical indications, such as joint replacement for severe arthritis, which the team hopes to pursue.

“We are eager to replicate these findings in larger and more diverse cohorts,” says Dr. LeBrasseur. “Also, we’re very excited to see how interventions, such as exercise, diet and, in the not-too-distant future, drugs, impact our biomarkers and, in turn, health outcomes. We have strong evidence in animal models for such approaches.”

This study touches on a long-term interest of Dr. LeBrasseur's lab and Mayo Clinic.

“Mayo has been a leader in demonstrating the fundamental role of senescent cells in aging and a host of aging-related diseases and geriatric syndromes,” says Dr. LeBrasseur. His lab has been a part of this effort, trying to answer the question of how researchers can measure biological age and better distinguish between biological age and chronological age.

“Clearly, there are robust and resilient older adults who exhibit very few consequences of aging, and more vulnerable and affected persons of similar chronological age,” says Dr. LeBrasseur. “As age is, by far, the greatest risk factor for the majority of health conditions that Mayo Clinic helps individuals manage, strategies to define biological age can help guide clinical decision-making.”

Dr. LeBrasseur’s lab has been a part of Mayo’s effort to demonstrate the fundamental role of senescent cells in aging, diseases and geriatric syndromes. Specifically, his team is trying to clarify how researchers can measure biological age and better distinguish between biological age and chronological age.

Also, Dr. LeBrasseur says, as interventions that target the fundamental biology of aging emerge, biomarkers of aging can help us identify individuals who will be most responsive. They also will serve as early indicators of whether the intervention is doing what it is intended to do, relative to measures of physical or cognitive function, for example.

“By better understanding the biology of aging, we have the potential to identify ways to fundamentally transform human health. Strategies to delay the onset of age-related diseases and disabilities would dramatically extend human health span, the period of life free of disease and disability. These efforts are facilitated by the collaborative, multidisciplinary nature of research at Mayo Clinic.”

Funding for this research was provided by federal grants; the Glenn Foundation for Medical Research; Pritzker Foundation; Beverly Foundation; and Leonard and Mary Lou Hoeft Fund in Healthy Aging and Independent Living Research. Also, Mayo Clinic Center for Individualized Medicine provided access to Mayo Clinic Biobank samples and data. Dr. LeBrasseur reports that he has financial interest related to this research, and Mayo Clinic holds patents on senolytic drugs.

Learn more

Read more stories about advances in individualized medicine.

Register to get weekly updates from the Mayo Clinic Center for Individualized Medicine blog.

Join the conversation

For more information on the Mayo Clinic Center for Individualized Medicine, visit FacebookLinkedIn or Twitter at @MayoClinicCIM

Tags: biomarkers, cells, individualized medicine, Research, Uncategorized

Words are empty when spoken. A big thank you to GOD and to Dr. Godsent Yare for using his effective herbal healing product to reverse my ALS/MND disease. I was diagnosed with ALS/MND disease three years back. My symptoms progressed so very fast that I couldn't do anything. I had tripping, dropping, abnormal fatigue of my leg, slurred speech, muscle cramps, and twitches. I was very depressed and had no hope of living. I couldn't resist it than to go deep into research for an alternative cure. On my search on the internet 2 months back, I stumbled upon Jessica Lannard blog via a Twitter post, and I'm so glad I did. She wrote on how she got cured by Dr. Godsent Yare of HSV 2 and I also saw this you-tube link https://youtu.be/Uw-l6rfcOl4 she added on her comment about a Lady from India who also shared her ALS CURE testimony and the wonders of Dr. Godsent Yare herbal healing herbs. At this time, I was curious. To cut it short, I visited Dr. Yare's website on http//bit.ly/2dBFYeW, and I got more knowledge about his cure which motivated me to take my orders. I received the product and used it as instructed for four weeks. Omg, during the second week of usage, I noticed great changes in my body system, all my symptoms gradually disappeared one by one. In the fourth week, I have totally cured of ALS/MND the hideous disease. Today makes it one month after usage and I can boldly tell the public that I have been reversed from ALS/MND disease. This is more than a miracle, I just can't believe my life is back again because my doctor at Mayo Clinic already told me there is no cure to ALS/MND. last 2 weeks I resumed work and I can now do all activities myself without anyone's assistance. You that are out there searching for a solution to that disease or problem, I have brought good news to you; that the cure is out there. With Dr. Godsent Yare all hope is not lost. if you need help to cure Parkinson's HIV, CORONAVIRUS, MS, MND, HBV, HSV1-2, Diabetes, cancer, etc. He can also help restore broken marriages, get your ex-husband, wife back. if you have any court case or any problem you can reach him directly by WhatsApp +2348164653711 Please let us share this to help others. Thank you so much Jessica Lanard for Sharing Dr. Yare's contact on your Blog that lead to my healing and a Big Thank You to Dr. Godsent Yare for your Herbal Healing products that saved my life. I'll keep on sharing the good work you are doing to save a life. you are truly Godsent I'll forever remain grateful and keep on recommending others who need help to your website for additional information. When people know better, they do better!

For help my email is; santoshchoud565@gmail.com I'll be glad to help.

Please sign in or register to post a reply.
Contact Us · Privacy Policy